448 related articles for article (PubMed ID: 10522070)
1. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
[TBL] [Abstract][Full Text] [Related]
3. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
Schütze K; Hentschel E; Hirschl AM
Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
5. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
6. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
7. [Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
Gisbert JP; Boixeda D; de Rafael L; Redondo C; Martín de Argila C; Bermejo F
Rev Esp Enferm Dig; 1996 May; 88(5):317-22. PubMed ID: 8764537
[TBL] [Abstract][Full Text] [Related]
8. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
[TBL] [Abstract][Full Text] [Related]
9. Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Lo WC; Lin HJ; Wang K; Perng CL; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):171-6. PubMed ID: 9198292
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Vakil N; Fennerty MB
Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
[TBL] [Abstract][Full Text] [Related]
11. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
12. Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients.
Figueroa G; Acuña R; Troncoso M; Portell DP; Toledo MS; Albornoz V; Vigneaux J
Am J Gastroenterol; 1996 Jul; 91(7):1395-9. PubMed ID: 8678002
[TBL] [Abstract][Full Text] [Related]
13. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
[TBL] [Abstract][Full Text] [Related]
14. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
[TBL] [Abstract][Full Text] [Related]
15. [What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
Gisbert JP; Boixeda D; de Rafael L; Alvarez Baleriola I; Martín de Argila C; García M; García Plaza A
Rev Esp Enferm Dig; 1996 Mar; 88(3):179-84. PubMed ID: 8645510
[TBL] [Abstract][Full Text] [Related]
16. [Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Labenz J; Gyenes E; Rühl GH; Börsch G
Med Klin (Munich); 1993 May; 88(5):297-9. PubMed ID: 8326916
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
18. Triple therapy and Helicobacter pylori.
Davis S
Aust Fam Physician; 1996 Jan; 25(1):53, 56-9. PubMed ID: 8607776
[TBL] [Abstract][Full Text] [Related]
19. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
Hentschel E; Brandstätter G; Dragosics B; Hirschl AM; Nemec H; Schütze K; Taufer M; Wurzer H
N Engl J Med; 1993 Feb; 328(5):308-12. PubMed ID: 8419816
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A
Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]